Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy

Published in: Biochemical and Biophysical Research Communications

Volume 333, Issue 2, pp. 328-335

DOI: 10.1016/j.bbrc.2005.05.132